Skip to main content

Qube Research & Technologies Ltd

Position in IDXX — Idexx Laboratories Inc /De

CIK 1729829 LONDON, X0

Position in IDXX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$48,125,878
+$37,829,768 QoQ
Shares Held
85,650
+462.8% QoQ
Ownership
0.109%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2021
16 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in IDXX Over Time

Shares Held

Position Value (USD)

Derivatives in IDXX

reported options exposure · as of Sep 30, 2025
CallValue
$383,334
CallShares
600
PutValue
$191,667
PutShares
300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

Qube Research & Technologies Ltd holds $924,641,036 across 18 Diagnostics & Research names. IDXX ranks #6 (5.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 IDXX
Idexx Laboratories Inc /De
This page
85,650 $48,125,878

All Filings in IDXX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $48,125,878 85,650
2025-12-31 $10,296,110 15,219
2025-09-30 $383,334 600
2025-09-30 $5,668,870 8,873
2025-09-30 $191,667 300
2025-06-30 $1,877,190 3,500
2025-06-30 $3,265,774 6,089
2025-06-30 $53,634 100
2025-03-31 $2,939,650 7,000
2025-03-31 $110,874,779 264,019
2024-12-31 $91,451,274 221,196
2024-12-31 $3,720,960 9,000
2024-09-30 $144,605,078 286,222
2024-09-30 $10,003,356 19,800
2024-06-30 $27,137,040 55,700
2024-06-30 $116,999,618 240,147
2024-03-31 $21,651,193 40,100
2024-03-31 $161,299,227 298,741
2023-12-31 $31,723,327 57,154
2023-09-30 $50,491,129 115,469
2023-06-30 $21,071,059 41,955
2023-03-31 $10,439,170 20,875
2022-09-30 $13,047,638 40,048
2022-06-30 $48,005,467 136,873
2021-03-31 $10,338,141 21,128